Table 5.
Underweight U M (SD) | Normal N M (SD) | Overweight Ov M (SD) | Obesity Ob M (SD) | Total M (SD) | df | F | p |
Post hoc
|
||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
U v N | U v Ov | U v Ob | N v Ov | N v Ob | Ov v Ob | |||||||||
Age (years) |
19.91 (1.74) |
19.96 (1.72) |
20.53 (1.74) |
21.15 (2.30) |
20.03 (1.74) |
3, 1483 |
7.892 |
0.001*** |
|
|
* |
** |
* |
|
Physical activity (frequency) |
2.49 (1.15) |
2.53 (1.09) |
2.51 (1.04) |
2.60 (0.94) |
2.53 (1.08) |
3, 1466 |
0.089 |
0.966 |
|
|
|
|
|
|
Diet Quality Index (frequency) |
12.31 (2.31) |
12.18 (2.11) |
12.29 (2.09) |
13.00 (1.30) |
12.21 (2.11) |
3, 1466 |
1.135 |
0.334 |
|
|
|
|
|
|
Overall drug use |
1.52 (0.38) |
1.59 (0.37) |
1.64 (0.35) |
1.71 (0.47) |
1.59 (0.37) |
3, 1443 |
2.210 |
0.085 |
|
|
|
|
|
|
High-frequency drug use |
2.24 (0.84) |
2.47 (0.89) |
2.62 (0.84) |
2.48 (0.96) |
2.47 (0.88) |
3, 1462 |
3.055 |
0.028* |
|
* |
|
|
|
|
Medium-frequency drug use |
1.29 (0.52) |
1.27 (0.51) |
1.27 (0.46) |
1.60 (0.82) |
1.28 (0.52) |
3, 1462 |
2.688 |
0.045* |
|
|
|
|
* |
|
Low-frequency drug use | 1.02 (0.08) | 1.03 (0.16) | 1.03 (0.11) | 1.03 (0.11) | 1.03 (0.15) | 3, 1450 | 0.068 | 0.977 |
Women.
Note: Significance levels for each ANOVA and Scheffé’s post-hoc comparison are depicted by: *p < 0.05, **p < 0.01, ***p < 0.005.